vs

Side-by-side financial comparison of Adaptive Biotechnologies Corp (ADPT) and Core Scientific, Inc. (CORZ). Click either name above to swap in a different company.

Core Scientific, Inc. is the larger business by last-quarter revenue ($79.8M vs $70.9M, roughly 1.1× Adaptive Biotechnologies Corp). Core Scientific, Inc. runs the higher net margin — 268.5% vs 4.7%, a 263.7% gap on every dollar of revenue. On growth, Adaptive Biotechnologies Corp posted the faster year-over-year revenue change (35.1% vs -16.0%). Over the past eight quarters, Adaptive Biotechnologies Corp's revenue compounded faster (28.1% CAGR vs -33.3%).

ExpreS2ion Biotechnologies is a Danish biotechnology company specialised in the development of new vaccines and immunotherapy products based in Hørsholm, Denmark and listed on the Nasdaq First North Growth Market Sweden.

Core Scientific is a leading digital asset and high-performance computing infrastructure provider. It operates large energy-efficient data centers across North America, offering cryptocurrency mining services, colocation hosting for blockchain and AI clients, and custom high-performance computing solutions for enterprise tech segments.

ADPT vs CORZ — Head-to-Head

Bigger by revenue
CORZ
CORZ
1.1× larger
CORZ
$79.8M
$70.9M
ADPT
Growing faster (revenue YoY)
ADPT
ADPT
+51.1% gap
ADPT
35.1%
-16.0%
CORZ
Higher net margin
CORZ
CORZ
263.7% more per $
CORZ
268.5%
4.7%
ADPT
Faster 2-yr revenue CAGR
ADPT
ADPT
Annualised
ADPT
28.1%
-33.3%
CORZ

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ADPT
ADPT
CORZ
CORZ
Revenue
$70.9M
$79.8M
Net Profit
$3.4M
$214.2M
Gross Margin
73.6%
26.0%
Operating Margin
-27.1%
-149.5%
Net Margin
4.7%
268.5%
Revenue YoY
35.1%
-16.0%
Net Profit YoY
180.6%
EPS (diluted)
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADPT
ADPT
CORZ
CORZ
Q1 26
$70.9M
Q4 25
$71.7M
$79.8M
Q3 25
$94.0M
$81.1M
Q2 25
$58.9M
$78.6M
Q1 25
$52.4M
$79.5M
Q4 24
$47.5M
$94.9M
Q3 24
$46.4M
$95.4M
Q2 24
$43.2M
$141.1M
Net Profit
ADPT
ADPT
CORZ
CORZ
Q1 26
$3.4M
Q4 25
$-13.6M
$214.2M
Q3 25
$9.5M
$-144.0M
Q2 25
$-25.6M
$-936.8M
Q1 25
$-29.9M
$576.3M
Q4 24
$-33.7M
$-265.5M
Q3 24
$-32.1M
$-455.3M
Q2 24
$-46.2M
$-902.2M
Gross Margin
ADPT
ADPT
CORZ
CORZ
Q1 26
73.6%
Q4 25
74.6%
26.0%
Q3 25
80.7%
4.8%
Q2 25
69.4%
6.4%
Q1 25
67.6%
10.3%
Q4 24
62.0%
5.0%
Q3 24
64.1%
-0.2%
Q2 24
55.3%
27.5%
Operating Margin
ADPT
ADPT
CORZ
CORZ
Q1 26
-27.1%
Q4 25
-17.8%
-149.5%
Q3 25
10.9%
-67.6%
Q2 25
-42.5%
-33.4%
Q1 25
-56.4%
-59.1%
Q4 24
-71.3%
-41.9%
Q3 24
-70.3%
-43.2%
Q2 24
-109.6%
-64.3%
Net Margin
ADPT
ADPT
CORZ
CORZ
Q1 26
4.7%
Q4 25
-18.9%
268.5%
Q3 25
10.2%
-177.6%
Q2 25
-43.5%
-1191.4%
Q1 25
-56.9%
724.6%
Q4 24
-71.0%
-279.7%
Q3 24
-69.1%
-477.4%
Q2 24
-107.0%
-639.4%
EPS (diluted)
ADPT
ADPT
CORZ
CORZ
Q1 26
Q4 25
$-0.08
$-1.63
Q3 25
$0.06
$-0.45
Q2 25
$-0.17
$-0.04
Q1 25
$-0.20
$1.24
Q4 24
$-0.22
$0.51
Q3 24
$-0.22
$-1.17
Q2 24
$-0.31
$-5.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADPT
ADPT
CORZ
CORZ
Cash + ST InvestmentsLiquidity on hand
$77.6M
$311.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$-962.7M
Total Assets
$505.9M
$2.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADPT
ADPT
CORZ
CORZ
Q1 26
$77.6M
Q4 25
$70.5M
$311.4M
Q3 25
$55.0M
$453.4M
Q2 25
$43.2M
$581.3M
Q1 25
$50.6M
$697.9M
Q4 24
$47.9M
$836.2M
Q3 24
$38.1M
$253.0M
Q2 24
$59.8M
$96.1M
Stockholders' Equity
ADPT
ADPT
CORZ
CORZ
Q1 26
Q4 25
$218.8M
$-962.7M
Q3 25
$204.4M
$-1.3B
Q2 25
$179.7M
$-1.2B
Q1 25
$190.4M
$-308.8M
Q4 24
$202.7M
$-943.0M
Q3 24
$223.8M
$-826.7M
Q2 24
$241.6M
$-1.2B
Total Assets
ADPT
ADPT
CORZ
CORZ
Q1 26
$505.9M
Q4 25
$512.7M
$2.3B
Q3 25
$490.6M
$2.2B
Q2 25
$496.6M
$1.9B
Q1 25
$510.9M
$1.5B
Q4 24
$539.4M
$1.5B
Q3 24
$558.5M
$824.6M
Q2 24
$584.9M
$664.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADPT
ADPT
CORZ
CORZ
Operating Cash FlowLast quarter
$278.3M
Free Cash FlowOCF − Capex
$-450.8M
FCF MarginFCF / Revenue
-565.1%
Capex IntensityCapex / Revenue
914.0%
Cash ConversionOCF / Net Profit
1.30×
TTM Free Cash FlowTrailing 4 quarters
$-779.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADPT
ADPT
CORZ
CORZ
Q1 26
Q4 25
$2.1M
$278.3M
Q3 25
$-7.1M
$131.8M
Q2 25
$-12.4M
$34.0M
Q1 25
$-28.5M
$-45.0M
Q4 24
$-12.5M
$42.9M
Q3 24
$-27.1M
$5.7M
Q2 24
$-17.3M
$1.2M
Free Cash Flow
ADPT
ADPT
CORZ
CORZ
Q1 26
Q4 25
$1.4M
$-450.8M
Q3 25
$-7.5M
$-112.7M
Q2 25
$-13.1M
$-87.3M
Q1 25
$-29.7M
$-129.0M
Q4 24
$-12.6M
$-52.1M
Q3 24
$-27.4M
$-25.5M
Q2 24
$-19.0M
$-1.9M
FCF Margin
ADPT
ADPT
CORZ
CORZ
Q1 26
Q4 25
2.0%
-565.1%
Q3 25
-8.0%
-139.0%
Q2 25
-22.2%
-111.0%
Q1 25
-56.7%
-162.2%
Q4 24
-26.5%
-54.8%
Q3 24
-59.0%
-26.7%
Q2 24
-44.1%
-1.4%
Capex Intensity
ADPT
ADPT
CORZ
CORZ
Q1 26
Q4 25
0.9%
914.0%
Q3 25
0.4%
301.5%
Q2 25
1.1%
154.2%
Q1 25
2.4%
105.6%
Q4 24
0.2%
100.0%
Q3 24
0.7%
32.7%
Q2 24
4.0%
2.2%
Cash Conversion
ADPT
ADPT
CORZ
CORZ
Q1 26
Q4 25
1.30×
Q3 25
-0.75×
Q2 25
Q1 25
-0.08×
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADPT
ADPT

Segment breakdown not available.

CORZ
CORZ

Other$36.3M46%
Digital Asset Self Mining Service$31.8M40%
Colocation Service$11.6M15%

Related Comparisons